Wigren M - Search Results

1

Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.

Svenungsson E, Engelbertsen D, Wigren M, Gustafsson JT, Gunnarsson I, Elvin K, Jensen-Urstad K, Fredrikson GN, Nilsson J. Svenungsson E, et al. Among authors: wigren m. Clin Exp Immunol. 2015 Sep;181(3):417-26. doi: 10.1111/cei.12651. Epub 2015 Jun 22. Clin Exp Immunol. 2015. PMID: 25959453 Free PMC article.

2

Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.

Ström A, Wigren M, Hultgårdh-Nilsson A, Saxena A, Gomez MF, Cardell S, Fredrikson GN, Nilsson J. Ström A, et al. Among authors: wigren m. Circ Res. 2007 Oct 12;101(8):e83-9. doi: 10.1161/CIRCRESAHA.107.160705. Epub 2007 Sep 20. Circ Res. 2007. PMID: 17885216

3

Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells.

Wigren M, Bengtsson D, Dunér P, Olofsson K, Björkbacka H, Bengtsson E, Fredrikson GN, Nilsson J. Wigren M, et al. Circ Res. 2009 Jun 19;104(12):e62-70. doi: 10.1161/CIRCRESAHA.109.196667. Epub 2009 May 28. Circ Res. 2009. PMID: 19478203

4

FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Zhao M, Wigren M, Dunér P, Kolbus D, Olofsson KE, Björkbacka H, Nilsson J, Fredrikson GN. Zhao M, et al. Among authors: wigren m. J Immunol. 2010 Mar 1;184(5):2253-60. doi: 10.4049/jimmunol.0902654. Epub 2010 Jan 22. J Immunol. 2010. PMID: 20097865

5

Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.

Nilsson J, Wigren M, Shah PK. Nilsson J, et al. Among authors: wigren m. Trends Cardiovasc Med. 2009 Nov;19(8):272-6. doi: 10.1016/j.tcm.2010.02.010. Trends Cardiovasc Med. 2009. PMID: 20447570 Review.

6

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.

Wigren M, Kolbus D, Dunér P, Ljungcrantz I, Söderberg I, Björkbacka H, Fredrikson GN, Nilsson J. Wigren M, et al. J Intern Med. 2011 May;269(5):546-56. doi: 10.1111/j.1365-2796.2010.02311.x. Epub 2010 Nov 29. J Intern Med. 2011. PMID: 21114693 Free article.

7

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.

Kolbus D, Ramos OH, Berg KE, Persson J, Wigren M, Björkbacka H, Fredrikson GN, Nilsson J. Kolbus D, et al. Among authors: wigren m. BMC Immunol. 2010 Dec 2;11:58. doi: 10.1186/1471-2172-11-58. BMC Immunol. 2010. PMID: 21126329 Free PMC article.

8

Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.

Kolbus D, Wigren M, Ljungcrantz I, Söderberg I, Alm R, Björkbacka H, Nilsson J, Fredrikson GN. Kolbus D, et al. Among authors: wigren m. Immunobiology. 2011 Jun;216(6):663-9. doi: 10.1016/j.imbio.2010.11.003. Epub 2010 Nov 19. Immunobiology. 2011. PMID: 21247654

9

Lymphocytes in atherosclerosis.

Wigren M, Nilsson J, Kolbus D. Wigren M, et al. Clin Chim Acta. 2012 Oct 9;413(19-20):1562-8. doi: 10.1016/j.cca.2012.04.031. Epub 2012 May 4. Clin Chim Acta. 2012. PMID: 22565046 Review.

10

Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke.

Wigren M, Björkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, Bryngelsson C, Hedblad B, Nilsson J. Wigren M, et al. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2000-4. doi: 10.1161/ATVBAHA.112.251579. Epub 2012 May 24. Arterioscler Thromb Vasc Biol. 2012. PMID: 22628434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters